Vericel VCEL will be releasing its next round of earnings this Tuesday, Nov. 6. For all of the relevant information, here is your guide for the Q3 earnings announcement.
Earnings and Revenue
Vericel EPS will likely be near a loss of 11 cents while revenue will be around $18.14 million, according to analysts.
In the same quarter last year, Vericel posted a loss of 16 cents on sales of $14.26 million. The analyst consensus estimate would represent a 31.25 percent decrease in the company's earnings. Revenue would be up 27.21 percent from the year-ago period. Vericel's reported EPS has stacked up against analyst estimates in the past like this:
| Quarter | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 |
| EPS Estimate | -0.12 | -0.13 | -0.07 | -0.16 |
| EPS Actual | -0.12 | -0.21 | 0.03 | -0.16 |
Stock Performance
Over the last 52-week period, shares are up 173.18 percent. Given that these returns are generally positive, long-term shareholders can be content going into this earnings release. Analyst estimates are adjusted higher for EPS and revenues over the past 90 days. The most common rating from analysts on Vericel stock is a Neutral. The strength of this rating has risen over the past three months.
Conference Call
Vericel is scheduled to hold a conference call at 8:30 a.m. ET and it can be accessed here: https://edge.media-server.com/m6/p/jssdcec8
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
